Cargando…

The function of a heterozygous p53 mutation in a Li-Fraumeni syndrome patient

p53 is one of the most extensively studied proteins in cancer research. Mutations in p53 generally abolish normal p53 function, and some mutants can gain new oncogenic functions. However, the mechanisms underlying p53 mutation-driven cancer remains to be elucidated. Our study investigated the functi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yang, Li, Ting, Tang, Yuejia, Zhan, Zhiyan, Ding, Lixia, Song, Lili, Yu, Tingting, Yang, Yi, Ma, Jing, Zhang, Yingwen, Zhou, Ying, Gu, Song, Xu, Min, Gao, Yijin, Li, Yanxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282642/ https://www.ncbi.nlm.nih.gov/pubmed/32516327 http://dx.doi.org/10.1371/journal.pone.0234262

Ejemplares similares

Molecular mechanism of c‐Myc and PRPS1/2 against thiopurine resistance in Burkitt's lymphoma
por: Li, Ting, et al.
Publicado: (2020)

Constitutional p53 mutation in a non-Li-Fraumeni cancer family.
por: Prosser, J., et al.
Publicado: (1992)

Li-Fraumeni Syndrome
por: Vogel, Wendy H.
Publicado: (2017)

Germline TP53 Mutation and Clinical Characteristics of Korean Patients With Li-Fraumeni Syndrome
por: Park, Kyoung-Jin, et al.
Publicado: (2016)

Heterogeneity of Li-Fraumeni Syndrome links to unequal gain-of-function effects of p53 mutations
por: Xu, Jie, et al.
Publicado: (2014)

A novel germline mutation of TP53 with breast cancer diagnosed as Li–Fraumeni syndrome
por: Kai, Masaya, et al.
Publicado: (2022)

The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype
por: Ruijs, Marielle WG, et al.
Publicado: (2009)

Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes
por: Frebourg, Thierry, et al.
Publicado: (2020)

Linkage studies in a Li-Fraumeni family with increased expression of p53 protein but no germline mutation in p53.
por: Birch, J. M., et al.
Publicado: (1994)

Chromosome instability in fibroblasts derived from Li–Fraumeni syndrome families without TP53 mutations
por: Boyle, J M, et al.
Publicado: (2000)

A Novel Variant in the TP53 Gene Causing Li–Fraumeni Syndrome
por: Papadimitriou, Dimitrios T., et al.
Publicado: (2023)

A novel TP53 tandem duplication in a child with Li–Fraumeni syndrome
por: Xu, Feng, et al.
Publicado: (2022)

Hematologic malignancies and Li–Fraumeni syndrome
por: Swaminathan, Mahesh, et al.
Publicado: (2019)

A new therapeutic basis for treating Li-Fraumeni Syndrome breast tumors expressing mutated TP53
por: Glazer, Robert I.
Publicado: (2010)

Genomic alterations associated with loss of heterozygosity for TP53 in Li-Fraumeni syndrome fibroblasts
por: Burt, E C, et al.
Publicado: (2000)

Arsenic trioxide extends survival of Li–Fraumeni syndrome mimicking mouse
por: Li, Jiabing, et al.
Publicado: (2023)

Chemoprevention with the metabolism modifying drugs dichloroacetate and metformin in the Li-Fraumeni Syndrome model, Trp53(+/-) mice
por: Blackburn, Anneke C, et al.
Publicado: (2014)

Radiation-induced G(1) arrest is not defective in fibroblasts from Li-Fraumeni families without TP53 mutations
por: Boyle, J M, et al.
Publicado: (1999)

Identification of a novel germ-line mutation in the TP53 gene in a Mexican family with Li-Fraumeni syndrome
por: Taja-Chayeb, Lucia, et al.
Publicado: (2009)

A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li–Fraumeni-like families
por: Calvete, Oriol, et al.
Publicado: (2015)

Li–Fraumeni Syndrome: Mutation of TP53 Is a Biomarker of Hereditary Predisposition to Tumor: New Insights and Advances in the Treatment
por: Rocca, Valentina, et al.
Publicado: (2022)

The first documentation of Li-Fraumeni syndrome in Korea.
por: Bang, Y. J., et al.
Publicado: (1995)

Pediatric Case of Li–Fraumeni Syndrome in Honduras
por: Martínez-Beckerat, R., et al.
Publicado: (2021)

Inhibiting the Priming for Cancer in Li-Fraumeni Syndrome
por: Pantziarka, Pan, et al.
Publicado: (2022)

A Case of Li-Fraumeni Associated Thymoma
por: Sivayoganathan, Thibacg, et al.
Publicado: (2022)

Does PTEN gene mutation play any role in Li-Fraumeni syndrome
por: Akouchekian, Mansoureh, et al.
Publicado: (2016)

NSCLC With Synchronous EGFR Mutations in Li Fraumeni Syndrome: A Case Report
por: Marks, Jennifer A., et al.
Publicado: (2023)

Cancer spectrum in TP53-deficient golden Syrian hamsters: A new model for Li-Fraumeni syndrome
por: Miao, Jinxin, et al.
Publicado: (2021)

The profile and contribution of rare germline copy number variants to cancer risk in Li-Fraumeni patients negative for TP53 mutations
por: Silva, Amanda G, et al.
Publicado: (2014)

Two Li-Fraumeni syndrome families with novel germline p53 mutations: loss of the wild-type p53 allele in only 50% of tumours.
por: Sedlacek, Z., et al.
Publicado: (1998)

A novel TP53 splicing mutation in a Li-Fraumeni syndrome family: a patient with Wilms' tumour is not a mutation carrier.
por: Varley, J. M., et al.
Publicado: (1998)

Li-Fraumeni syndrome--a molecular and clinical review.
por: Varley, J. M., et al.
Publicado: (1997)

Li-Fraumeni Syndrome: A Rare Genetic Disorder
por: Tazin, Faria, et al.
Publicado: (2022)

Case report of a Li–Fraumeni syndrome-like phenotype with a de novo mutation in CHEK2
por: Zhuang, Xuehan, et al.
Publicado: (2016)

Genetic and functional analysis of a Li Fraumeni syndrome family in China
por: Hu, Huaying, et al.
Publicado: (2016)

Identification and characterization of TP53 gene Allele Dropout in Li-Fraumeni syndrome and Oral cancer cohorts
por: Haque, Mohammed Moquitul, et al.
Publicado: (2018)

The relationship between radiation-induced G(1)arrest and chromosome aberrations in Li-Fraumeni fibroblasts with or without germline TP53 mutations
por: Boyle, J M, et al.
Publicado: (2001)

Identification of a TP53 Mutation in a Patient With Li-Fraumeni Syndrome and Not Meeting the Revised Chompret Criteria: A Case Report
por: Iwasaki, Monika, et al.
Publicado: (2023)

Li‐Fraumeni versus Pseudo‐Li‐Fraumeni Syndrome: Key Insights for Interpreting Next‐Generation Sequencing Reports in Patients with Suspected Cancer Predisposition Syndromes
por: Sorscher, Steven, et al.
Publicado: (2017)

TP53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause Li-Fraumeni syndrome
por: Ribi, Sebastian, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tcsiodv3cl2ur12m50kvvfge6j